MGM
ABBV icon

Miura Global Management’s AbbVie ABBV Stock Holding History

Miura Global Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-350,000
Closed -$19.8M – 23
2014
Q2 		$19.8M Buy
+350,000
New +$18.4M 1.52% 20

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Miura Global Management's ABBV Position: Q3 2014 in Review

Miura Global Management sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 350,000 shares — an estimated $19.8M sold.

Miura Global Management first reported a position in ABBV in Q2 2014 and held it in 1 quarter. The position peaked at $19.8M in Q2 2014. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • Miura Global Management reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
  • Miura Global Management sold 350,000 AbbVie shares in Q3 2014, an estimated $19.8M.
  • Miura Global Management first reported a position in AbbVie in Q2 2014 and held it in 1 quarter.
  • Miura Global Management's AbbVie position peaked at $19.8M in Q2 2014.
  • 1,503 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Miura Global Management's 13F filing for Q3 2014, filed 14 Nov 2014.